Zoetis (NYSE:ZTS) has entered into a definitive agreement to acquire Neogen Corporation's animal genomics business. The ...

Acquisition strengthens Zoetis’ leadership in precision animal health by integrating Neogen’s global genomics capabilities, expanding predictive insights and individualized care worldwide.

Replacement heifer selection has always shaped herd direction. Today, genomic tools are reshaping how confidently those decisions are made.

Research shared at Kansas State University’s 113th Cattlemen’s Day showed cows that shed earlier can wean calves more than 40 ...

The Texas A&M University System Board of Regents has approved the establishment of the Center for Comparative Genomics in animal genetics. The center will contribute to genomic advances in human and ...

Zoetis Inc. expects to close the acquisition of Neogen Corp.’s animal genomics business in the second half of 2026.

Animal health company Zoetis and Neogen Corporation, a food and animal safety solution provider, have entered into a definitive acquisition agreement. Under the $160 million deal, ...

Sequencing the genomes of domestic animals could be beneficial to animal production practices, animal health and welfare, and to our understanding of the genetic basis of diseases in both animals and ...

10x Genomics, Inc., a company focused on accelerating genomic discovery, today launched a new version of their de novo assembly solution to provide the fastest most cost-effective solution for ...

AnimalBiome, the leading companion animal microbiome company, has selected Loop Genomics long-read 16S Microbiome kits to help it expand its microbiome testing capabilities to provide veterinarians ...

Forbes contributors publish independent expert analyses and insights. Steven Savage writes about technologies enabling modern agriculture The Plant and Animal Genomics scientific conference was held ...

Investing.com -- Zoetis (NYSE:ZTS) shares fell 1.55% Monday after the animal health company announced it will acquire Neogen Corporation’s (NASDAQ:NEOG) animal genomics business for $160 million.